Host-viral epigenetic interactions in HPV16-mediated oropharyngeal cancer
Richard Shaw, Anastasia Filia, Janet Risk, Terry Jones, Triantafillos Liloglou
University of Liverpool, UK
Proffered paper presentation
Background
Recent
evidence suggests that HPV-16 is involved in the development of oropharyngeal
carcinoma (OPSCC). Crosstalk between the viral genome and the epigenetic
machinery of the host may represent critical aetiological mechanisms. Regarding
therapeutic HPV vaccine clinical trials, biomarkers indicating pathogenesis of
viral oncoproteins would have clinical value. In this study we assess the frequency of
HPV-16 in a retrospective cohort and identify the relevant methylation
patterns of both the HPV-16 and host genomes.
Methods
DNA
was extracted from 55 oropharynx samples. HPV-16 identification was undertaken
by duplicate PCR reactions utilising HPV-16/E6 specific primers. Multiple
positive and negative controls were included to eliminate false
positive/negative results. Also, confirmation of HPV-16 typing was achieved by
sequencing all positive PCR products. DNA methylation analysis for the HPV LCR
region and the genomic LINE-1 retrotransposable element (global methylation)
was undertaken by pyrosequencing.
Results
Twenty-two
of 55 (40%) of the OPSCC samples examined were HPV positive. Sequencing
confirmed the HPV-16 type in all cases. Hypomethylation of LINE-1 (methylation
index<65%) was demonstrated in 29/55 (53.7%) samples. No significant
differences in the global methylation (LINE-1) index were found between the HPV
positive/negative groups. Regarding the DNA methylation status of the LCR
region of the HPV genome, only 1/23 HPV-16 positive tumours showed significant
methylation (MtI =84%).
Conclusion
HPV
DNA is present in a substantial percentage of OPSCC, thus it may play a role in
its pathogenesis. This finding is important for the HPV-vaccine based clinical
trials. The presence of HPV DNA does not affect global methylation of the host.
It still remains to be evaluated whether the expression of specific HPV16 genes
may affect this process. The LCR region, which controls the expression of
E6/E7, is not frequently methylated in OPSCC, while the status of the E2 -
located CpG island remains to be examined.